Atp6ap1l, a pseudogene orthologous to human ATP6AP1L, plays a crucial role in the regulation of cellular pH by being part of the plasma membrane proton-transporting V-type ATPase complex. Predicted to be involved in the regulation of cellular pH, Atp6ap1l contributes to maintaining the acidic environment within lysosomes, a key factor in various cellular processes. While its exact functions are still being elucidated, Atp6ap1l emerges as a significant player in cellular pH homeostasis, influencing lysosomal function and proton transport. The activation of Atp6ap1l involves a diverse array of chemical regulators that impact lysosomal acidification, proton transport, and cellular pH homeostasis. Compounds such as Bafilomycin A1, Chloroquine, and Concanamycin A act as V-ATPase inhibitors, suppressing lysosomal proton transport and indirectly activating Atp6ap1l by modulating pH regulation. Nigericin and Omeprazole disrupt intracellular pH, indirectly promoting Atp6ap1l expression by influencing the proton gradient and lysosomal acidification. Ammonium chloride (NH4Cl) and Salicylihalamide A further modulate lysosomal pH, indirectly promoting Atp6ap1l expression by impacting proton transport and acidification.
Lysosomotropic agents, V-ATPase inhibitors, and specific compounds like Resveratrol collectively contribute to the indirect activation of Atp6ap1l by influencing cellular pathways involved in pH regulation. Amiloride, a sodium-proton exchanger inhibitor, impacts intracellular pH, while Zoledronic acid, a bisphosphonate, influences lysosomal pH and function, both indirectly promoting Atp6ap1l expression. In conclusion, Atp6ap1l is intricately linked to the regulation of cellular pH and lysosomal function. Its activation involves a network of chemical regulators that modulate proton transport, lysosomal acidification, and overall pH homeostasis. The diverse array of chemicals influencing Atp6ap1l underscores its significance in cellular processes, shedding light on its role in maintaining the delicate balance of pH within lysosomes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
V-ATPase inhibitor, suppressing lysosomal proton transport, indirectly activating Atp6ap1l by modulating pH regulation and plasma membrane V-type ATPase complex. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Lysosomotropic agent, impacting lysosomal function and pH regulation, indirectly promoting Atp6ap1l expression by modulating cellular pH homeostasis. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
V-ATPase inhibitor, influencing lysosomal acidification, indirectly activating Atp6ap1l by modulating pH within lysosomal compartments. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
Monensin analog, disrupting intracellular pH, indirectly promoting Atp6ap1l by influencing the proton gradient and pH regulation. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Proton pump inhibitor, impacting cellular pH homeostasis, indirectly activating Atp6ap1l by modulating proton transport and lysosomal acidification. | ||||||
FCM Lysing solution (1x) | sc-3621 | 150 ml | $62.00 | 8 | ||
Influencing lysosomal pH, this solution indirectly promotes Atp6ap1l expression by modulating proton transport and acidification within lysosomes. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Sodium-proton exchanger inhibitor, impacting intracellular pH, indirectly promoting Atp6ap1l expression by modulating proton transport and pH regulation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
SIRT1 activator, influencing cellular pathways involved in pH regulation, indirectly activating Atp6ap1l expression by modulating pH homeostasis. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Bisphosphonate, influencing lysosomal pH and function, indirectly activating Atp6ap1l by modulating proton transport and lysosomal acidification. | ||||||